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  The clinical effect of Prazosin， an alpha blocking agent， was studied in 18 patients with neurogenic
bladder dysfunction． The patients consisted of l l supranuclear and 7 infranticlear type according
to the neurological examinations． The daily doses of O．5一一4 mg of Prazosin was given for 1 week
to 6 months． The result was． as follows： excellent ip 8， good in 3 and poor in 7 cases． The overall
success rate was 610／o （5 cases in supranuclear． type and 6 cases in infrahuclear type）． A few side
effects were no’狽??such ”aS’@orthostatic hypotensign， n4gsea，． diqrrhea and urinary frequency． Thus，
Prazosin seems to be an effective drug for treatment of neurogeniC bladder dysfunction．


















 交感神経遮断剤，特にα一adrenergic blocking agents
が，ある種の神経因性膀胱に効果を見ることは，一般
に認められている． そのなかでも，phenoxy benza－
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Fig． i． prazosinの化学構造式
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